Jonathan Melamed mainly focuses on Prostate cancer, Cancer research, Pathology, Internal medicine and Prostate. His research in Prostate cancer is mostly focused on Androgen receptor. His Cancer research study combines topics from a wide range of disciplines, such as Carcinogenesis, microRNA, Oncogene and Transcription factor.
His study in the field of Carcinoma, Clear cell, Differential diagnosis and Immunohistochemistry is also linked to topics like Kurtosis. He interconnects Gastroenterology and Endocrinology in the investigation of issues within Internal medicine. Within one scientific family, he focuses on topics pertaining to Urology under Prostate, and may sometimes address concerns connected to Rectal examination, Prostate-specific antigen, High-grade prostatic intraepithelial neoplasia and Adenocarcinoma.
His scientific interests lie mostly in Prostate cancer, Pathology, Internal medicine, Prostate and Cancer research. His Prostate cancer research is multidisciplinary, incorporating elements of Biopsy and Magnetic resonance imaging. His research on Pathology often connects related topics like Adenocarcinoma.
His Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology and Oncology. As part of the same scientific family, Jonathan Melamed usually focuses on Cancer research, concentrating on LNCaP and intersecting with Molecular biology. His Androgen receptor research includes elements of Androgen and Gene knockdown.
His primary scientific interests are in Prostate cancer, Pathology, Cancer research, Radiology and Prostate. His Prostate cancer research incorporates elements of Magnetic resonance imaging and Oncology. His research investigates the link between Pathology and topics such as Penis that cross with problems in Neoplasm.
His Cancer research research integrates issues from Immunohistochemistry, Downregulation and upregulation, Transcription factor, Transfection and microRNA. His study on Radiology also encompasses disciplines like
His primary areas of study are Prostate cancer, Cancer research, Prostate, Biopsy and Pathology. His Prostate cancer study deals with the bigger picture of Cancer. His Cancer research research is multidisciplinary, relying on both Oncogene, Downregulation and upregulation, Chromatin, microRNA and Signal transduction.
His study in Prostate focuses on Prostatectomy in particular. His Biopsy research is multidisciplinary, incorporating elements of Intraepithelial neoplasia, Carcinoma, Cribriform and Nuclear atypia. His Pathology research incorporates elements of Imaging phantom and Nuclear medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma
Geert J.L.H. van Leenders;Theodorus H. van der Kwast;David J. Grignon;Andrew J. Evans.
The American Journal of Surgical Pathology (2005)
Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence
Juan C. Acosta;Ana O'Loghlen;Ana Banito;Maria V. Guijarro.
Cell (2008)
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.
Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf.
Cell (2018)
A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion–Resistant Growth
Zhiyong Guo;Xi Yang;Feng Sun;Richeng Jiang.
Cancer Research (2009)
Genomic and Functional Approaches to Understanding Cancer Aneuploidy
Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao.
Cancer Cell (2018)
TWO CONSECUTIVE SETS OF TRANSRECTAL ULTRASOUND GUIDED SEXTANT BIOPSIES OF THE PROSTATE FOR THE DETECTION OF PROSTATE CANCER
Michael A. Levine;Michael Ittman;Jonathan Melamed;Herbert Lepor.
The Journal of Urology (1998)
Standards of Reporting for MRI-targeted Biopsy Studies (START) of the Prostate: Recommendations from an International Working Group.
Caroline M. Moore;Veeru Kasivisvanathan;Scott Eggener;Mark Emberton.
European Urology (2013)
Regulation of androgen receptor activity by tyrosine phosphorylation
Zhiyong Guo;Bojie Dai;Tianyun Jiang;Kexin Xu.
Cancer Cell (2006)
Re: A Prospective, Blinded Comparison of Magnetic Resonance (MR) Imaging-Ultrasound Fusion and Visual Estimation in the Performance of MR-Targeted Prostate Biopsy: The PROFUS Trial
James S. Wysock;Andrew B. Rosenkrantz;William C. Huang;Michael D. Stifelman.
European Urology (2014)
Erratum: Comprehensive Characterization of Cancer Driver Genes and Mutations (ARTICLE (2018) 173(2) (371–385), (S009286741830237X), (10.1016/j.cell.2018.02.060))
Matthew H. Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta.
Cell (2018)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
New York University
New York University
New York University
Memorial Sloan Kettering Cancer Center
New York University
New York University
University of Pennsylvania
New York University
Baylor College of Medicine
Icahn School of Medicine at Mount Sinai
University of Science and Technology of China
Pusan National University
KU Leuven
Cincinnati Children's Hospital Medical Center
Centers for Disease Control and Prevention
University of Georgia
University of KwaZulu-Natal
University of Glasgow
University of Sydney
Technical University of Munich
University of Nottingham
University of California, San Francisco
University of Pennsylvania
Technical University of Madrid
University of Kentucky
Radboud University Nijmegen